Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II trial of TNFerade initiated in patients with esophageal cancer

Nov. 18, 2002

Chemoprotective agent heads for clinical trials at ProMetic

Nov. 18, 2002

Compounds that directly inhibit the androgen receptor discovered at Praecis

Nov. 18, 2002

Novel inhibitors of CDK and GSK-3 identified by Schering researchers

Nov. 15, 2002

Vertex advances Aurora kinase inhibitor into preclinical development

Nov. 14, 2002

Pretreatment of solid tumors with NHS76/PEP2 improves efficacy of chemotherapy in mice

Nov. 14, 2002

Human interferon beta gene therapy with selective activity against RCC

Nov. 13, 2002

Cannabis-based medicine advances to phase II trials in patients undergoing chemotherapy

Nov. 13, 2002

Urokinase inhibitors with utility in cancer covered by Pentapharm patent

Nov. 13, 2002

Taisho claims preparation and use of two series of VEGF antagonists

Nov. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...